Predictors of Pneumonitis in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Definitive Chemoradiation Followed by Consolidative Durvalumab.

Diamond, Brett H; Belani, Neel; Masel, Rebecca; DeCarli, Kathryn; DiPetrillo, Thomas; Hepel, Jaroslaw T; Azzoli, Christopher G; Khurshid, Humera; Abbas, Abbas; Koffer, Paul P

Diamond, Brett H; Belani, Neel; Masel, Rebecca; DeCarli, Kathryn; DiPetrillo, Thomas; Hepel, Jaroslaw T; Azzoli, Christopher G; Khurshid, Humera; Abbas, Abbas; Koffer, Paul P.

Afiliação

Diamond BH; Department of Radiation Oncology, Rhode Island Hospital, Providence, Rhode Island.
Belani N; Department of Radiation Oncology, Tufts Medical Center, Boston, Massachusetts.
Masel R; Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
DeCarli K; Department of Medicine, Rhode Island Hospital, Providence, Rhode Island.
DiPetrillo T; Warren Alpert School of Medicine, Providence, Rhode Island.
Hepel JT; Department of Medical Oncology, Rhode Island Hospital, Providence, Rhode Island.
Azzoli CG; Department of Radiation Oncology, Rhode Island Hospital, Providence, Rhode Island.
Khurshid H; Department of Radiation Oncology, Tufts Medical Center, Boston, Massachusetts.
Abbas A; Warren Alpert School of Medicine, Providence, Rhode Island.
Koffer PP; Department of Radiation Oncology, Rhode Island Hospital, Providence, Rhode Island.

Adv Radiat Oncol ; 8(2): 101130, 2023.

Article em En | MEDLINE | ID: mdl-36845618

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google